14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PCVX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Vaxcyte, Inc. stock upgraded to Buy Candidate.
(Updated on May 02, 2024)

Buy candidate since May 02, 2024 PDF

The Vaxcyte, Inc. stock price gained 1.32% on the last trading day (Thursday, 2nd May 2024), rising from $63.71 to $64.55. During the last trading day the stock fluctuated 2.99% from a day low at $63.11 to a day high of $65.00. The price has risen in 6 of the last 10 days and is up by 6.48% over the past 2 weeks. Volume fell on the last day by -265 thousand shares and in total, 474 thousand shares were bought and sold for approximately $30.61 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -20.48% during the next 3 months and, with a 90% probability hold a price between $46.62 and $53.97 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PCVX Signals & Forecast

Mostly positive signals in the chart today. The Vaxcyte, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $61.56 and $64.36. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, April 25, 2024, and so far it has risen 7.48%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Vaxcyte, Inc. stock

Vaxcyte, Inc. finds support from accumulated volume at $64.43 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $1.89 (2.99%) between high and low. For the last week, the stock has had daily average volatility of 3.77%.

Our recommended stop-loss: $62.46 (-3.24%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 5 days ago.)

Trading Expectations (PCVX) For The Upcoming Trading Day Of Friday 3rd

For the upcoming trading day on Friday, 3rd we expect Vaxcyte, Inc. to open at $64.22, and during the day (based on 14 day Average True Range), to move between $62.30 and $66.80, which gives a possible trading interval of +/-$2.25 (+/-3.48%) up or down from last closing price. If Vaxcyte, Inc. takes out the full calculated possible swing range there will be an estimated 6.96% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $64.43 (0.19%) than the resistance at $69.70 (7.98%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Vaxcyte, Inc. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

Current score: 2.784 Buy Candidate Upgraded

Predicted Opening Price for Vaxcyte, Inc. of Friday, May 3, 2024

Fair opening price May 3, 2024 Current price
$64.22 ( 0.512%) $64.55

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PCVX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 66.11 2.41 %
R2 65.39 1.30 %
R1 64.94 0.605 %
Current price: 64.55
Support S1 63.50 -1.63 %
S2 63.05 -2.32 %
S3 62.33 -3.44 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 75.11 16.36 %
R2 74.15 14.87 %
R1 69.70 7.98 %
Current price 64.55
Support S1 64.43 -0.186%
S2 60.83 -5.76%
S3 60.06 -6.96%

FAQ

What is the symbol for Vaxcyte, Inc. Stock and on which exchange is it traded?
The symbol for Vaxcyte, Inc. is PCVX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Vaxcyte, Inc. Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

How to buy Vaxcyte, Inc. Stock?
Vaxcyte, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Vaxcyte, Inc. Stock.

What's the current price of Vaxcyte, Inc. Stock?
As of the end of day on the May 02, 2024, the price of an Vaxcyte, Inc. (PCVX) share was $64.55.

What is the 52-week high and low for Vaxcyte, Inc. Stock?
The 52-week high for Vaxcyte, Inc. Stock is $82.04 and the 52-week low is $44.20.

What is the market capitalization of Vaxcyte, Inc. Stock?
As of the May 02, 2024, the market capitalization of Vaxcyte, Inc. is 6.929B.

When is the next earnings date for Vaxcyte, Inc.?
The upcoming earnings date for Vaxcyte, Inc. is May 13, 2024.
Click to get the best stock tips daily for free!

About Vaxcyte, Inc.

Vaxcyte. Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company also develops VAX-XP to protect against emerging strains and address antibiotic resistance; VAX-A1, a co... PCVX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT